88 related articles for article (PubMed ID: 7539887)
1. Amino acid residues in the third alpha-helix of growth hormone involved in growth promoting activity.
Chen WY; Chen NY; Yun J; Wight DC; Wang XZ; Wagner TE; Kopchick JJ
Mol Endocrinol; 1995 Mar; 9(3):292-302. PubMed ID: 7539887
[TBL] [Abstract][Full Text] [Related]
2. Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice.
Chen XZ; Shafer AW; Yun JS; Li YS; Wagner TE; Kopchick JJ
Mol Endocrinol; 1992 Apr; 6(4):598-606. PubMed ID: 1584223
[TBL] [Abstract][Full Text] [Related]
3. Glycine 119 of bovine growth hormone is critical for growth-promoting activity.
Chen WY; Wight DC; Mehta BV; Wagner TE; Kopchick JJ
Mol Endocrinol; 1991 Dec; 5(12):1845-52. PubMed ID: 1791834
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the third alpha-helix of bovine growth hormone dramatically affect its intracellular distribution in vitro and growth enhancement in transgenic mice.
Chen WY; Wight DC; Chen NY; Coleman TA; Wagner TE; Kopchick JJ
J Biol Chem; 1991 Feb; 266(4):2252-8. PubMed ID: 1989980
[TBL] [Abstract][Full Text] [Related]
5. In-vitro mutagenesis of the bovine growth hormone gene.
Kopchick JJ; McAndrew SJ; Shafer A; Blue WT; Yun JS; Wagner TE; Chen WY
J Reprod Fertil Suppl; 1990; 41():25-35. PubMed ID: 2213712
[TBL] [Abstract][Full Text] [Related]
6. Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice.
Chen WY; White ME; Wagner TE; Kopchick JJ
Endocrinology; 1991 Sep; 129(3):1402-8. PubMed ID: 1874179
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo studies of antagonistic effects of human growth hormone analogs.
Chen WY; Chen NY; Yun J; Wagner TE; Kopchick JJ
J Biol Chem; 1994 Jun; 269(22):15892-7. PubMed ID: 8195244
[TBL] [Abstract][Full Text] [Related]
8. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice.
Chen NY; Chen WY; Bellush L; Yang CW; Striker LJ; Striker GE; Kopchick JJ
Endocrinology; 1995 Feb; 136(2):660-7. PubMed ID: 7835300
[TBL] [Abstract][Full Text] [Related]
9. Expression of a mutated bovine growth hormone gene suppresses growth of transgenic mice.
Chen WY; Wight DC; Wagner TE; Kopchick JJ
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5061-5. PubMed ID: 2367524
[TBL] [Abstract][Full Text] [Related]
10. Glomerulosclerosis and body growth are mediated by different portions of bovine growth hormone. Studies in transgenic mice.
Yang CW; Striker LJ; Pesce C; Chen WY; Peten EP; Elliot S; Doi T; Kopchick JJ; Striker GE
Lab Invest; 1993 Jan; 68(1):62-70. PubMed ID: 8423678
[TBL] [Abstract][Full Text] [Related]
11. A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes.
Okada S; Chen WY; Wiehl P; Kelder B; Goodman HM; Guller S; Sonenberg M; Kopchick JJ
Endocrinology; 1992 Apr; 130(4):2284-90. PubMed ID: 1547740
[TBL] [Abstract][Full Text] [Related]
12. Effects of an S84E mutation of bovine growth hormone in transgenic mice.
Schenck EJ; Brooks CL
Exp Biol Med (Maywood); 2006 Mar; 231(3):296-302. PubMed ID: 16514176
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
[TBL] [Abstract][Full Text] [Related]
14. A growth hormone (GH) analog that antagonizes the lipolytic effect but retains full insulin-like (antilipolytic) activity of GH.
Campbell RM; Chen WY; Wiehl P; Kelder B; Kopchick JJ; Scanes CG
Proc Soc Exp Biol Med; 1993 Jul; 203(3):311-6. PubMed ID: 8516343
[TBL] [Abstract][Full Text] [Related]
15. Location of an epitope defined by an enhancing monoclonal antibody to growth hormone: some structural details and biological implications.
Beattie J; Holder AT
Mol Endocrinol; 1994 Aug; 8(8):1103-10. PubMed ID: 7527900
[TBL] [Abstract][Full Text] [Related]
16. Discovery and development of a new class of drugs: GH antagonists.
Kopchick JJ
J Endocrinol Invest; 2003; 26(10 Suppl):16-26. PubMed ID: 15497656
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mice expressing either bovine growth hormone (bGH) or human GH releasing hormone (hGRH) have increased splenic progenitor cell colony formation and DNA synthesis in vitro and in vivo.
Blazar BR; Brennan CA; Broxmeyer HE; Shultz LD; Vallera DA
Exp Hematol; 1995 Dec; 23(13):1397-406. PubMed ID: 7498369
[TBL] [Abstract][Full Text] [Related]
18. Expression of insulin-like growth factor I stimulates normal somatic growth in growth hormone-deficient transgenic mice.
Behringer RR; Lewin TM; Quaife CJ; Palmiter RD; Brinster RL; D'Ercole AJ
Endocrinology; 1990 Sep; 127(3):1033-40. PubMed ID: 2387246
[TBL] [Abstract][Full Text] [Related]
19. Bovine growth hormone transgenic mice display alterations in locomotor activity and brain monoamine neurochemistry.
Söderpalm B; Ericson M; Bohlooly M; Engel JA; Törnell J
Endocrinology; 1999 Dec; 140(12):5619-25. PubMed ID: 10579325
[TBL] [Abstract][Full Text] [Related]
20. Ovine placental lactogen is a potent somatogen in the growth hormone (GH)-deficient rat: comparison of somatogenic activity with bovine GH.
Singh K; Ambler GR; Breier BH; Klempt M; Gluckman PD
Endocrinology; 1992 May; 130(5):2758-66. PubMed ID: 1374015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
